Escitalopram and Emtriva drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Escitalopram (escitalopram oxalate) and Emtriva (emtricitabine). Common drug interactions include pain among males.
The phase IV clinical study analyzes what interactions people have when they take Escitalopram and Emtriva. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.
What is Escitalopram?
Escitalopram has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 78,080 Escitalopram users. Check the latest studies of Escitalopram.
What is Emtriva?
Emtriva has active ingredients of emtricitabine. eHealthMe is studying from 2,383 Emtriva users. Check the latest studies of Emtriva.
23 people who take Escitalopram and Emtriva together, and have interactions are studied.

What are the common drug interactions of Escitalopram and Emtriva, by gender? *:
female:
n/a
male:
- Pain
- Chronic kidney disease
- Quality of life decreased
- Renal tubular necrosis (death of kidney tubules)
- Hypokalaemia (low potassium)
- Osteonecrosis (death of bone)
- Proteinuria (presence of protein in the urine)
- Anaemia (lack of blood)
- Back pain
- Blood creatinine increased
What are the common drug interactions of Escitalopram and Emtriva, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Chronic kidney disease
- Emotional distress
- Fatigue (feeling of tiredness)
- Pain
- Foot fracture
- Lethargy (tiredness)
- Osteoporosis (bones weak and more likely to break)
- Decreased activity
- Quality of life decreased
50-59:
- Chronic kidney disease
- Pain
- Emotional distress
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Renal failure (kidney dysfunction)
- Osteoporosis (bones weak and more likely to break)
- Renal tubular necrosis (death of kidney tubules)
- Bone density decreased
- Decreased activity
- Fatigue (feeling of tiredness)
60+:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Bone density decreased
- Staphylococcus test positive
- Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
- Tooth disorder (tooth disease)
- Dyspepsia (indigestion)
- Emotional distress
- Foot fracture
- Hip fracture
- Impaired work ability
What are the existing conditions these people have? *
- Hiv Infection: 19 people, 82.61%
- High Blood Pressure: 8 people, 34.78%
- Pain: 7 people, 30.43%
- Stress And Anxiety: 6 people, 26.09%
- Asthma: 5 people, 21.74%
- Bacterial Infection: 5 people, 21.74%
- Insomnia (sleeplessness): 5 people, 21.74%
- Chest Pain: 4 people, 17.39%
- Constipation: 4 people, 17.39%
- Gastric Ulcer (stomach ulcer): 4 people, 17.39%
* Approximation only. Some reports may have incomplete information.
Do you take Escitalopram and Emtriva?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Escitalopram (78,080 reports)
- Emtriva (2,383 reports)
Browse all drug interactions of Escitalopram and Emtriva:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Escitalopram:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Emtriva:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Escitalopram and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Emtriva and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on escitalopram oxalate and emtricitabine (the active ingredients of Escitalopram and Emtriva, respectively), and Escitalopram and Emtriva (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lunesta cause Papilloma Viral Infection? - 10 seconds ago
- Bursitis and Abdominal Discomfort - 12 seconds ago
- Could Cytosar-U cause Rashes? - 16 seconds ago
- Drug interactions of Azulfidine and Omnaris - 18 seconds ago
- Drug interactions of Imipenem And Cilastatin and Xanax - 19 seconds ago
- Could Furosemide cause Hepatocellular Carcinoma? - 21 seconds ago
- Drug interactions of Norepinephrine Bitartrate and Primacor - 22 seconds ago
- Drug interactions of Reopro and Altace - 32 seconds ago
- Drug interactions of Testosterone and Cyclophosphamide - 34 seconds ago
- Drug interactions of Imbruvica and Singulair - 39 seconds ago